What Caught Our Attention in the Investment World? – Week of September 26-30, 2022

By Kuldip K. Ambastha On Thursday, September 29, 2022, the stock price of CarMax, Inc. (KMX), a used vehicle retailer, dropped by -24.6% per share. The American company’s latest quarterly performance results disappointed Wall Street, especially from the perspective of earnings per share (EPS). The current landscape of high inflation, higher interest rates (making for …

What Caught Our Attention in the Investment World? – Week of September 19-23, 2022

By Kuldip K. Ambastha The stock price of Sotera Health Company (SHC), an integrated global health solutions company, had a loss of -33.3% per share on Monday, September 19, 2022. On the subsequent trading days of the week, three negative daily returns and one positive daily return were seen. Litigation was the primary cause of …

What Caught Our Attention in the Investment World? – Week of September 12-16, 2022

By Kuldip K. Ambastha On Thursday, September 15, 2022, the stock of Spectrum Brands Holdings, Inc. (SPB), a branded consumer products company, fell in price by -16.2% per share. Within Spectrum Brands Holdings, there is a residential door hardware division offering the Baldwin and Kwikset brands. A rival company had expressed interest in acquiring this …

What Caught Our Attention in the Investment World? – Week of September 6-9, 2022

By Kuldip K. Ambastha The stock of Regeneron Pharmaceuticals, Inc. (REGN), a biotechnology company with a portfolio of medicines for individuals with serious diseases, increased in price by +18.8% per share on the trading day of Thursday, September 8, 2022. Eylea (aka: aflibercept), an anti-blindness eye medication, was the cause of this price run-up, because …

What Caught Our Attention in the Investment World? – Week of August 29-September 2, 2022

By Kuldip K. Ambastha On Thursday, September 1, 2022, the stock of Okta, Inc. (OKTA), a technology company providing cloud-based identity management support for businesses, fell in price by -33.7% per share for the trading day. While 2Q2022 results surpassed Wall Street expectations, areas of concern on a going forward basis drove this sharp decline …

What Caught Our Attention in the Investment World? – Week of September 27-October 1, 2021

By Kuldip K. Ambastha The stock of Dollar Tree, Inc. (DLTR), a prominent discount variety store chain operator in North America, had an impressive gain of +16.5% for the trading day of Wednesday, September 29, 2021. As dollar store chains have faced rising inflationary, raw material cost, freight shipping cost, and labor cost pressures, store …

What Caught Our Attention in the Investment World? – Week of September 20-24, 2021

By Kuldip K. Ambastha Toast, Inc. (TOST) had its initial public offering (IPO) of Class A common stock on Wednesday, September 22, 2021 through the New York Stock Exchange (NYSE). Toast, Inc. is a cloud-based restaurant software company headquartered in Boston, MA. The company has an all-in-one point-of-sale and restaurant management platform used by food …

What Caught Our Attention in the Investment World? – Week of September 13-17, 2021

By Kuldip K. Ambastha During this past trading week, stocks in the casino sector suffered greatly. After positive daily returns on Monday, September 13, negative daily returns were mostly seen for the rest of the trading week for Las Vegas Sands Corporation (LVS) and Wynn Resorts, Limited (WYNN) per the table seen above (except for …

What Caught Our Attention in the Investment World? – Week of September 6-10, 2021

By Kuldip K. Ambastha On Thursday, September 9, 2021, the stock of Lululemon Athletica Inc. (LULU) had a gain of +10.5%. Lululemon Athletica is a prominent company in the athletic apparel and accessories sector, focused on product offerings for yoga, running, and other physical pursuits. A strongly positive 2Q2021 earnings announcement drove the gain in …

What Caught Our Attention in the Investment World? – Week of August 30-September 3, 2021

By Kuldip K. Ambastha On Friday, September 3, 2021, the stock of Forte Biosciences, Inc. (FBRX) stood out for its substantial trading day loss of -82.3%. Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on potential treatments for inflammatory skin diseases. The company released results of a Phase 2 clinical trial of FB-401, related …